Dolby Laboratories (NYSE:DLB – Get Free Report) is anticipated to post its Q1 2026 results after the market closes on Thursday, January 29th. Analysts expect Dolby Laboratories to post earnings of $0.90 per share and revenue of $341.2590 million for the quarter. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Individuals may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, January 29, 2026 at 5:00 PM ET.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The firm’s revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.61 EPS. On average, analysts expect Dolby Laboratories to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Dolby Laboratories Price Performance
Shares of NYSE DLB opened at $62.10 on Tuesday. The company has a market cap of $5.93 billion, a P/E ratio of 23.61 and a beta of 0.88. Dolby Laboratories has a 1 year low of $61.33 and a 1 year high of $89.66. The firm has a 50-day simple moving average of $65.35 and a two-hundred day simple moving average of $69.15.
Dolby Laboratories Increases Dividend
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the company. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Barrington Research reduced their price target on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Monday. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Thursday, January 22nd. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Insider Buying and Selling
In related news, EVP Mark Andrew Sherman sold 9,109 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the sale, the executive vice president owned 73,054 shares of the company’s stock, valued at $4,874,893.42. This trade represents a 11.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Yeaman sold 36,699 shares of Dolby Laboratories stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $66.91, for a total value of $2,455,530.09. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at $7,676,249.75. This trade represents a 24.24% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 137,120 shares of company stock valued at $9,184,809. 37.93% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Dolby Laboratories
Several institutional investors have recently bought and sold shares of DLB. Royal Bank of Canada lifted its holdings in shares of Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after purchasing an additional 2,298 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after buying an additional 171,288 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after acquiring an additional 12,598 shares in the last quarter. Focus Partners Wealth purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after acquiring an additional 1,902 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
